Transformed Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 1 |
DB15434 | Mosunetuzumab | 1 | Recruiting | 1 |
DB11703 | Acalabrutinib | 1 / 2 | Recruiting | 1 |
DB14776 | Camrelizumab | 1 / 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 1 / 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
DB14765 | Rivoceranib | 1 / 2 | Recruiting | 1 |
DB14922 | Tislelizumab | 1 / 2 | Recruiting | 1 |
DB15043 | Toripalimab | 1 / 2 | Recruiting | 1 |
DB00135 | Tyrosine | 1 / 2 | Recruiting | 1 |
DB00541 | Vincristine | 1 / 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB00987 | Cytarabine | 2 | Recruiting | 1 |
DB01234 | Dexamethasone | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB00773 | Etoposide | 2 | Recruiting | 1 |
DB09054 | Idelalisib | 2 | Active Not Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Recruiting | 1 |
DB00541 | Vincristine | 2 | Recruiting | 1 |